ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 351 filers reported holding ENCOMPASS HEALTH CORP in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $357,000 | -60.7% | 7,900 | -51.2% | 0.00% | -50.0% |
| Q2 2022 | $908,000 | +410.1% | 16,200 | +546.2% | 0.00% | – |
| Q1 2022 | $178,000 | -91.4% | 2,507 | -90.9% | 0.00% | -100.0% |
| Q3 2021 | $2,064,000 | +2168.1% | 27,500 | +1764.4% | 0.00% | – |
| Q2 2020 | $91,000 | -89.9% | 1,475 | -89.5% | 0.00% | -100.0% |
| Q1 2020 | $901,000 | -48.6% | 14,077 | -44.4% | 0.00% | -33.3% |
| Q4 2019 | $1,752,000 | -9.2% | 25,299 | -17.1% | 0.00% | -25.0% |
| Q3 2019 | $1,930,000 | -74.2% | 30,502 | -74.2% | 0.00% | -73.3% |
| Q2 2019 | $7,485,000 | -63.1% | 118,136 | -66.0% | 0.02% | -61.5% |
| Q1 2019 | $20,273,000 | -24.5% | 347,146 | -20.3% | 0.04% | -35.0% |
| Q4 2018 | $26,868,000 | -9.2% | 435,500 | +14.7% | 0.06% | +9.1% |
| Q3 2018 | $29,605,000 | +62.1% | 379,800 | +40.8% | 0.06% | +57.1% |
| Q2 2018 | $18,264,000 | +36.9% | 269,700 | +15.6% | 0.04% | +59.1% |
| Q1 2018 | $13,338,000 | – | 233,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |